Currently, with respect to metastasis inhibition, most of the promising research have focused on tumor-associated macrophages (TAMs) and has been aimed at targeting on pro-metastatic factors such as CSF1 and CCL2 (16, 20, 21). Here, CCL2 is linked to neoplasm.